Plus Therapeutics, Inc. (PSTV)
6.71
+0.11
(+1.67%)
USD |
NASDAQ |
May 27, 14:53
Plus Therapeutics Cash from Investing (Quarterly) : -8.533M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -109.55M |
| AVITA Medical, Inc. | 2.041M |
| Twist Bioscience Corp. | -12.71M |
| Elutia, Inc. | -0.034M |
| TriSalus Life Sciences, Inc. | -0.141M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.238M |
| Cash from Financing (Quarterly) | 9.035M |
| Free Cash Flow | -21.72M |
| Free Cash Flow Per Share (Quarterly) | -1.062 |
| Free Cash Flow to Equity (Quarterly) | -6.96M |
| Free Cash Flow to Firm (Quarterly) | -7.039M |
| Free Cash Flow Yield | -52.10% |